Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

M. Kreuter; J. Vansteenkiste; J.R. Fischer; W. Eberhardt; H. Zabeck; J. Kollmeier; M. Serke; N. Frickhofen; M. Reck; W. Engel-Riedel; S. Neumann; M. Thomeer; C. Schumann; P. De Leyn; T. Graeter; G. Stamatis; I. Zuna; F. Griesinger; M. Thomas

doi:10.1093/annonc/mds578

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

Annals of Oncology ◽

10.1093/annonc/mds578 ◽

2013 ◽

Vol 24 (4) ◽

pp. 986-992 ◽

Cited By ~ 41

Author(s):

M. Kreuter ◽

J. Vansteenkiste ◽

J.R. Fischer ◽

W. Eberhardt ◽

H. Zabeck ◽

...

Keyword(s):

Adjuvant Chemotherapy ◽

Early Stage ◽

Phase 2 ◽

Phase 2 Trial ◽

Early Stage Nsclc ◽

Randomized Phase 2

Download Full-text

Re: Adjuvant Sandwich Chemotherapy plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy: A Randomized Phase 2 Trial

The Journal of Urology ◽

10.1097/01.ju.0000550152.18402.1f ◽

2019 ◽

Vol 201 (1) ◽

pp. 29-29

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Radical Cystectomy ◽

Locally Advanced ◽

Phase 2 ◽

Phase 2 Trial ◽

Advanced Bladder Cancer ◽

Randomized Phase 2

Download Full-text

Re: Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial

European Urology ◽

10.1016/j.eururo.2018.03.022 ◽

2018 ◽

Vol 74 (1) ◽

pp. 119

Author(s):

Marco Moschini ◽

Paul Sargos

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Radical Cystectomy ◽

Locally Advanced ◽

Phase 2 ◽

Phase 2 Trial ◽

Advanced Bladder Cancer ◽

Randomized Phase 2

Download Full-text

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Nature Medicine ◽

10.1038/s41591-021-01505-4 ◽

2021 ◽

Vol 27 (10) ◽

pp. 1818-1824

Author(s):

Carolyn Y. Ho ◽

Sharlene M. Day ◽

Anna Axelsson ◽

Mark W. Russell ◽

Kenneth Zahka ◽

...

Keyword(s):

Hypertrophic Cardiomyopathy ◽

Early Stage ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

Case Medical Research ◽

10.31525/ct1-nct04015778 ◽

2019 ◽

Author(s):

Keyword(s):

Exploratory Study ◽

Early Stage ◽

Phase 2 ◽

Early Stage Nsclc

Download Full-text

A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma

Acta Oncologica ◽

10.1080/0284186x.2021.1928281 ◽

2021 ◽

pp. 1-6

Author(s):

Peter C. Petersen ◽

Lone N. Petersen ◽

Ivan Vogelius ◽

Jon K. Bjerregaard ◽

Lene Baeksgaard

Keyword(s):

Phase 2 ◽

First Line ◽

Phase 2 Trial ◽

Randomized Phase 2 ◽

Esophagogastric Adenocarcinoma

Download Full-text

Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Oral Oncology ◽

10.1016/j.oraloncology.2021.105192 ◽

2021 ◽

Vol 115 ◽

pp. 105192

Author(s):

Douglas R. Adkins ◽

Jin-Ching Lin ◽

Assuntina Sacco ◽

Jessica Ley ◽

Peter Oppelt ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Human Papillomavirus ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Phase 2 ◽

Double Blind ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

P76.24 A Randomized Phase 2 Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-Line Therapy for EGFR-Negative NSCLC (ALTER-L018)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1081 ◽

2021 ◽

Vol 16 (3) ◽

pp. S596

Author(s):

L. Wu ◽

Z. Wu ◽

Z. Xiao ◽

J. Weng ◽

M. Xiao ◽

...

Keyword(s):

Phase 2 ◽

Phase 2 Trial ◽

Line Therapy ◽

Randomized Phase 2

Download Full-text

Seven Days Treatment With the Angiotensin II Type 2 Receptor Agonist C21 in Hospitalized COVID-19 Patients: A Placebo-Controlled Randomized Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3889369 ◽

2021 ◽

Author(s):

Göran Tornling ◽

Rohit Batta ◽

Joanna C. Porter ◽

Bryan Williams ◽

Thomas Bengtsson ◽

...

Keyword(s):

Angiotensin Ii ◽

Receptor Agonist ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Durvalumab, Tremelimumab Alone or in Combination With Low-Dose or Hypofractionated Targeted Radiotherapy in Metastatic Non-Small Cell Lung Cancer Refractory to Prior PD-1 Therapy: A Multicentre, Open-Label, Randomized, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3922682 ◽

2021 ◽

Author(s):

Jonathan D. Schoenfeld ◽

Anita Giobbie-Hurder ◽

Srinika Ranasinghe ◽

Katrina Z. Kao ◽

Ana Lako ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Low Dose ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Targeted Radiotherapy ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Abstract PD1-06: Trilaciclib improves overall survival when given with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: Final analysis of a randomized phase 2 trial

10.1158/1538-7445.sabcs20-pd1-06 ◽

2021 ◽

Author(s):

Joyce O'Shaughnessy ◽

Gail S Wright ◽

Anu R Thummala ◽

Michael A Danso ◽

Lazar Popovic ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Final Analysis ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text